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The disease-linked Glu-26-Lys mutant version of 
Coronin 1A exhibits pleiotropic and pathway-
specific signaling defects
Virginia Ojeda, Javier Robles-Valero, María Barreira, and Xosé R. Bustelo
Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de 
Investigaciones Científicas and University of Salamanca, 37007 Salamanca, Spain
ABSTRACT Coronin 1A (Coro1A) is involved in cytoskeletal and signaling events, including 
the regulation of Rac1 GTPase– and myosin II–dependent pathways. Mutations that generate 
truncated or unstable Coro1A proteins cause immunodeficiencies in both humans and ro-
dents. However, in the case of the peripheral T-cell–deficient (Ptcd) mouse strain, the immu-
nodeficiency is caused by a Glu-26-Lys mutation that targets a surface-exposed residue un-
likely to affect the intramolecular architecture and stability of the protein. Here we report 
that this mutation induces pleiotropic effects in Coro1A protein, including the exacerbation 
of Coro1A-dependent actin-binding and -bundling activities; the formation of large mesh-
works of Coro1AE26K-decorated filaments endowed with unusual organizational, functional, 
and staining properties; and the elimination of Coro1A functions associated with both Rac1 
and myosin II signaling. By contrast, it does not affect the ability of Coro1A to stimulate the 
nuclear factor of activated T-cells (NF-AT). Coro1AE26K is not a dominant-negative mutant, in-
dicating that its pathological effects are derived from the inability to rescue the complete loss 
of the wild-type counterpart in cells. These results indicate that Coro1AE26K behaves as either 
a recessive gain-of-function or loss-of-function mutant protein, depending on signaling con-
text and presence of the wild-type counterpart in cells.
INTRODUCTION
Coronin 1A (Coro1A; also known as tryptophan aspartate–contain-
ing coat protein, p57-coronin, and coronin-1) displays a complex 
structure that includes an N-terminal β-propeller domain composed 
of seven WD40 repeats (residues 1–352) that can bind F-actin, an 
adjacent C-terminal extension harboring both conserved (residues 
352–392) and unique (residues 393–429) sequences relative to other 
family members, and a distal coiled-coil region (residues 429–461) 
that can interact with the actin-related proteins 2 and 3 (Arp2/3) 
complex (Appleton et al., 2006; Uetrecht and Bear, 2006). This pro-
tein plays key roles in the regulation of lamellipodia dynamics due 
to its dual ability of stimulating and inhibiting F-actin bundling and 
the Arp2/3 complex, respectively (Uetrecht and Bear, 2006; Galkin 
et al., 2008; Shiow et al., 2008). More recently, it has been shown 
that Coro1A is also involved in the regulation of Rac1 signaling at 
two different levels. On one hand, it favors the stimulation of Rac1 
via F-actin–dependent interactions with p21-activated kinase (Pak), 
ArhGEF7 (also known as β-Pix and Cool1), and Rho GDP dissocia-
tion inhibitor (Rho GDI)–Rac1 complexes. These interactions favor 
the Pak-mediated phosphorylation and inactivation of Rho GDI, the 
release of Rac1 from phosphorylated Rho GDIs, and, subsequently, 
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to staining, structural, and regulatory criteria. Coro1AE26K does not 
have dominant-negative effects on the normal biological activity of 
its wild-type counterpart. However, it cannot functionally compen-
sate for the loss of the endogenous protein, which explains the dif-
ferent phenotypes exhibited by heterozygous and homozygous 
Ptcd mice.
RESULTS
Coro1AE26K promotes formation of filaments with unusual 
staining properties
To evaluate the effect of the E26K mutation in Coro1A function, we 
first transfected COS1 cells with vectors encoding either enhanced 
green fluorescent protein (GFP)– or red fluorescent protein (RFP)–
tagged versions of Coro1AE26K and, upon staining with fluores-
cence-labeled versions of phalloidin to decorate the cytoskeleton, 
analyzed them by confocal microscopy. For comparative purposes, 
we studied in parallel COS1 cells ectopically expressing wild-type 
Coro1A and Coro1AD278V, a protein harboring a missense mutation 
in a residue that, due to its location in the Coro1A structure (Apple-
ton et al., 2006), probably disrupts the functionality of the β-propeller 
domain. We chose those cells because they are Coro1A dependent 
(Castro-Castro et al., 2011; Bustelo et al., 2012; Ojeda et al., 2014) 
and, in addition, their large cytoplasms facilitate the visualization of 
cytoskeleton-related processes. Using this strategy, we observed 
that wild-type Coro1A-EGFP (Figure 1A, left) and Coro1A-RFP 
(Figure 1B, left) localize preferentially in membrane ruffle–rich areas 
and, in addition, throughout the cytoplasm of transfected cells. In 
some cases, these proteins are found in reticular structures through-
out the cytoplasm (Figure 1A). Such localization is disrupted in the 
case of Coro1AD278V-EGFP mutant (Figure 1A, middle), which shows 
a predominant cytoplasmic distribution, probably as a consequence 
of lack of actin binding. This distribution is similar to that previously 
described for another actin-deficient mutant version of this protein 
(Coro1AR29D; Castro-Castro et al., 2011). By contrast, we unexpect-
edly found that both Coro1AE26K-EGFP (Figure 1A, right) and Coro-
1AE26K-RFP (Figure 1B, right) show a quite idiosyncratic distribution, 
since they both localize in meshworks of very thick filaments uni-
formly distributed throughout the cytoplasm. The shape of these 
structures, which are not detected in control cells, is slightly different 
depending on the C-terminal tag, since the Coro1AE26K-RFP deco-
rated filaments are usually shorter and more fusiform (Figure 1B, 
right) than those found in Coro1AE26K-EGFP–expressing cells (Figure 
1A, right). These filaments are resistant to conventional staining with 
F-actin–binding molecules (phalloidin; Figure 1, A and B) and anti-
bodies to either myosin IIB (Supplemental Figure S1) or a number 
of intermediate filament (vimentin, cytokeratins) and microtubule 
(α-tubulin) markers (Figure 1C). The amount of ectopic expression of 
the wild-type and E26K mutant versions of Coro1A was similar in 
these cells (Figure 1D, top and middle; compare third and fourth 
lanes), indicating that the differential subcellular distribution exhib-
ited by each of those two chimeric proteins could not be just attrib-
uted to either different amounts of ectopic expression or differential 
overexpression relative to endogenous Coro1A (Figure 1D, top; 
compare first with third and fourth lanes). As expected, the endog-
enous protein was missing in CORO1A-knockdown COS1 cells 
(KD1A.1; Figure 1D, top; compare first and second lanes; Castro-
Castro et al., 2011; Ojeda et al., 2014). Coro1AE26K-EGFP also forms 
phalloidin-negative filaments when ectopically expressed in both 
HEK 293T (Figure 1E) and Jurkat cells (Figure 1F), indicating that this 
effect is not cell-type specific. As in the case of COS1 cells, these 
bundles are located away from areas of active cytoskeletal reorgani-
zation (Figure 1, E and F). This feature is most notable in Jurkat cells, 
the stimulation of Rac1 at the plasma membrane by either ArhGEF7 
or other upstream GDP/GTP exchange factors (Castro-Castro et al., 
2011; Bustelo et al., 2012). On the other hand, Coro1A is involved 
in an F-actin– and myosin II–dependent step that favors the intracel-
lular dynamics and cytoskeletal output of already activated Rac1-
AhrGEF7-Pak2 complexes. Owing to the latter function, the short 
hairpin RNA–mediated knockdown of CORO1A transcripts leads to 
the sequestration of those complexes in actomyosin ring structures 
and the formation of large, lamella-like cell protrusions instead of 
the membrane ruffles typically seen in active Rac1-expressing cells 
(Ojeda et al., 2014). Additional functions of this protein include 
vesicle trafficking, neurotrophin signaling and neurite outgrowth in 
neurons, signaling functions in endothelial cells, macrophage lipo-
protein uptake, mast cell degranulation, and lytic immune synapse 
formation in natural killer cells. It is also involved in the infective cy-
cle of a number of pathogens, such as Plasmodium falciparum and 
Mycobacterium species inside host cells (Jayachandran et al., 2007, 
2008; Foger et al., 2011; Holtta-Vuori et al., 2012; Seto et al., 2012; 
Liu et al., 2014; Mace and Orange, 2014; Suo et al., 2014; Terzi 
et al., 2014; Kim et al., 2015).
In addition to the foregoing functions, Coro1A has been the fo-
cus of recent attention due to the discovery that a number of severe 
human and mouse T-cell immunodeficiencies are caused by muta-
tions in its gene (Haraldsson et al., 2008; Shiow et al., 2008, 2009; 
Moshous et al., 2013; Stray-Pedersen et al., 2014; Punwani et al., 
2015). These observations have been confirmed using standard 
Coro1a-knockout mice (Foger et al., 2006; Mueller et al., 2008, 
2011; Mugnier et al., 2008), although there is still disagreement on 
whether the immunodeficiencies observed are caused by actin-de-
pendent or -independent mechanisms (Mueller et al., 2011). Most 
of the mutations found in this gene correspond to loss-of-function 
alleles that encode either truncated (p.P83X, p.Q262X, p.P83RfsX10, 
p.Q360Rfs44) or structurally unstable (p.D278V, p.V134M) mutant 
proteins (Haraldsson et al., 2008; Shiow et al., 2008, 2009; Moshous 
et al., 2013; Stray-Pedersen et al., 2014). However, the analysis of 
the Ptcd mouse strain revealed the presence of a mutation (E26K) in 
the Coro1A β-propeller domain (Shiow et al., 2008) that, according 
to structural criteria (Appleton et al., 2006), is unlikely to cause any 
obvious intrinsic structural defect in the protein. The exact localiza-
tion of this mutation in the structure of the protein is shown and 
discussed later in Figure 5A. However, this mutant protein shows an 
abnormal cytosolic distribution in cells, suggesting potential defects 
in its interaction with the cytoskeleton and/or cytoskeletal regulators 
(Shiow et al., 2008). Consistent with this idea, biochemical studies 
have shown that Coro1AE26K exhibits increased in vitro inhibitory ac-
tivity toward the Arp2/3 complex (Shiow et al., 2008). However, 
whether such activity is responsible for the in vivo defects of this 
mutant is unclear because, for example, the Coro1AE26K and the 
Arp2/3 complex do not seem to colocalize in cells (Shiow et al., 
2008). Such activity is also at odds with data indicating that the 
Coro1A β-propeller domain (the region where Glu-26 is located) 
and the Coro1A Arp2/3-binding site are not in physical proximity, at 
least when coronins are forming complexes with F-actin and the 
Arp2/3 complex (Cai et al., 2005; Appleton et al., 2006; Galkin et al., 
2008). These observations led us to study the biological features of 
this mutant protein. Here we report that the E26K mutation induces 
a gain-of-function effect that promotes exacerbated actin-binding 
and -bundling activities by Coro1A, as well as alterations in down-
stream signaling. Such property is dominant over the negative ef-
fects induced by loss-of-function mutations that disrupt association 
of Coro1A with actin. In vivo, Coro1AE26K promotes the formation of 
an extensive meshwork of filaments that is quite unusual according 
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(Figure 2, E and F). Despite the differential distribution shown by 
Coro1AE26K in these experiments, we did not observe any enrich-
ment of actin in the insoluble pellets obtained from Coro1AE26K-
expressing COS1 cells (Figure 2E, third from top) and Ptcd thymo-
cytes (Figure 2F, second from top). This suggests that the mutant 
protein recruits only a relatively small fraction of the total F-actin pres-
ent in cells. The detection of other proteins in the expected cytosolic 
(ectopic EGFP, endogenous glyceraldehyde-3-phosphate dehydro-
genase [GAPDH]) and insoluble (endogenous histone H3) fractions 
confirmed the proper purification of those fractions in both COS1 
cells (Figure 2E, bottom) and Ptcd thymocytes (Figure 2F, bottom).
Coro1AE26K filaments show intervening 
F-actin–rich segments
The foregoing results led us to consider whether the filaments in-
duced by Coro1AE26K could represent F-actin filaments that, for un-
known reasons, could not be stained by phalloidin. To assess this 
possibility, we reanalyzed the structure of filaments present in Coro-
1AE26K-expressing COS1 cells using other techniques that could 
facilitate the visualization of F-actin enriched structures. As a first 
experimental avenue, we used RFP-LifeAct, a fusion protein that 
contains a C-terminal 17–amino acid sequence derived from the 
Saccharomyces cerevisiae Abp140 actin-binding protein (Riedl 
et al., 2008). When expressed in cells, this bioreporter allows the 
visualization of F-actin filaments in both living and fixed cells using 
standard epifluorescence detection techniques (Riedl et al., 2008). 
Consistent with this, we observed that Coro1A-EGFP and RFP-Life-
Act colocalize in juxtamembrane areas of the transfected COS1 cells 
(Figure 3A). As a second experimental alternative, we stained Coro-
1AE26K-EGFP–expressing cells using antibodies to an epitope com-
mon to all actin isoforms. We observed using those two avenues 
that the Coro1AE26K-EGFP–decorated filaments are still mostly neg-
ative for both RFP-LifeAct–derived (Figure 3B) and actin-derived 
(Figure 3C) fluorescence signals. However, a more detailed exami-
nation of cells indicated that these fibers are interrupted in some 
cases by small Coro1AE26K-EGFP–negative segments that do show 
RFP-LifeAct epifluorescence (Figure 3B, arrows) and actin immuno-
reactivity (Figure 3C, arrows). Similar results are observed when 
Coro1AE26K-expressing COS1 cells are stained with Alexa Fluor 635–
labeled phalloidin (Figure 3D, arrows) or cotransfected with a GFP-
β-actin–encoding plasmid (Figure 3E, arrows). The latter technique 
was the only one that could find clear areas of colocalization of 
Coro1AE26K and β-actin in COS1 cells (Figure 3E). By contrast, 
we observed, using coexpression experiments, that Coro1AE26K 
does not block the incorporation of wild-type Coro1A in those fila-
ments (Figure 3F). We did not find any substantial colocalization of 
Coro1AE26K with both endogenously (Supplemental Figure S2A, 
second column from left) and ectopically (Supplemental Figure S2B) 
expressed γ-actin, an actin isoform that forms highly stable filaments 
that are resistant, for example, to latrunculin-induced depolymeriza-
tion (Baranwal et al., 2012). As control, endogenous γ-actin does 
show colocalization with ectopically EGFPs fused to wild-type 
Coro1A (Supplemental Figure S2A, first column from left) and the 
constitutively active Rac1Q61L and Vav1 oncoprotein (Supplemental 
Figure S2A, third and fourth columns from left, respectively) in these 
experiments. Similarly to COS1 cells, the Coro1AE26K-decorated 
filaments present in Ptcd thymocytes are also poorly stained with 
antibodies to actin (Figure 3G). Collectively these results indicate 
that the E26K mutation favors the formation of both Coro1A–F-actin 
complexes and Coro1A-decorated filaments in cells. These fila-
ments may represent F-actin structures that cannot be properly 
recognized by common F-actin binding reagents or, alternatively, 
because the Coro1AE26K-decorated filaments are specifically lo-
cated in the cortex of the cell body that protrudes away from the 
substratum (Figure 1F). To rule out artifacts derived from either the 
protein overexpression or C-terminal tags used in the foregoing ex-
periments, we next investigated the distribution of endogenous 
Coro1A in thymocytes obtained from Ptcd mice. To this end, we 
attached these cells to coverslips coated with antibodies to mouse 
CD3, fixed them, and stained them with both phalloidin and anti-
bodies to Coro1A. Using confocal immunofluorescence microscopy 
analysis, we found that the endogenous Coro1AE26K also displays a 
cortical distribution in phalloidin-negative filaments similar to that 
previously observed in Coro1AE26K-EGFP–expressing Jurkat cells 
(Figure 1G, right). By contrast, the endogenous Coro1A present 
in wild-type cells shows the expected distribution in phalloidin-
positive membrane ruffles that emanate from the thymocyte/
substrate contact zone (Figure 1G, left). These results indicate that 
the E26K mutation promotes a switch in the normal function of 
Coro1A, leading to the formation of thick, Coro1AE26K-decorated 
filaments that are located away from active areas of cytoskeletal 
reorganization.
Coro1AE26K shows increased interactions with actin 
in immunoprecipitation experiments
Given the lack of staining with usual markers for cytoskeletal, inter-
mediate filaments and microtubules, we next carried out proteomics 
experiments to get clues about the possible nature of the filaments 
generated by Coro1AE26K. To this end, we compared by electropho-
resis and mass spectrometry the protein complexes formed by 
EGFP-tagged wild-type Coro1A and Coro1AE26K in COS1 cells. As 
negative control, we performed similar experiments using the non-
chimeric EGFP. These analyses revealed that the two Coro1A-EGFPs, 
but not the EGFP alone, can associate with the heat shock proteins 
of 90 (Hsp90, Mowse score 130; see Materials and Methods) and 71 
(Hsp71, Mowse score 219) kDa, the T-complex protein 1 chaperonin 
(Tpc1, Mowse score 107), Coro1C (Mowse score 156), actin isoforms 
(β and γ; scores 258 and 276, respectively), and the Arp3 subunit of 
the Arp2/3 complex (Mowse score 205; Figure 2A). We also detected 
a band corresponding to bovine serum albumin (BSA) that was non-
specifically brought down in the immunoprecipitation of both 
Coro1A-EGFPs but not with the nonchimeric EGFP bait (Figure 2A, 
blue asterisk, Mowse score 173). Whereas most of those proteins 
coimmunoprecipitated at similar amounts with both the wild-type 
and E26K versions of Coro1A, we found that the actin isoforms and, 
to a much lesser extent, the Arp3 subunit and Coro1C associated at 
much higher amounts with the mutant Coro1A version (Figure 2A, 
compare lanes 2 and 3). This observation suggests that the E26K 
mutation probably increases either the affinity or the intracellular for-
mation of Coro1A–actin complexes. The increased in vivo associa-
tion of Coro1AE26K-EGFP with endogenous actin and Arp2/3 com-
plex proteins (Arpc2, also known as p34Arc) was confirmed using 
coimmunoprecipitation experiments in transiently transfected COS1 
cells (Figure 2, B, top, and C). This is even more conspicuous when 
these coimmunoprecipitation analyses are performed using endog-
enous proteins present in cell lysates derived from wild-type and ho-
mozygous Ptcd thymocytes (Figure 2D, top). Consistent with these 
results, we found that Coro1AE26K-EGFP and endogenous Coro-
1AE26K are preferentially localized in detergent- insoluble fractions of 
COS1 cells (Figure 2E) and Ptcd thymocytes (Figure 2F), respectively. 
These fractions are typically enriched in cytoskeletal and nuclear 
components and exclude proteins loosely attached to these cell 
structures. By contrast, wild-type Coro1A is distributed in both the 
cytosolic and insoluble fractions under both experimental conditions 
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FIGURE 1: Ectopic and endogenous Coro1AE26K decorate a phalloidin-negative filament meshwork. (A–C) Represen-
tative confocal images of COS1 cells expressing the indicated EGFP-tagged (A and C, green signals) and RFP-tagged 
(B, red signals) Coro1A versions (top) and stained with rhodamine-labeled phalloidin (A, red signals), Alexa Fluor 
635–labeled phalloidin (B, blue signals), or antibodies to the indicated proteins (C, red signals). Potential colocalization 
areas between Coro1A proteins and F-actin had to be seen in either yellow (A, bottom) or purple (B, bottom). Potential 
colocalization areas between Coro1A proteins and vimentin, pancytokeratins, or α-tubulin had to be seen in yellow (C). 
Scale bars, 10 μm. Insets, enlarged images of the indicated cell areas (white open squares). (D) Total cellular lysates 
obtained from parental COS1 cells, CORO1A knockdown (KD1A.1) COS1 cells, and parental COS1 cells (bottom) 
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properties of this protein (Castro-Castro et al., 2011; Ojeda et al., 
2014; Figure 5A). Given the strong positive effect of the E26K 
mutation on the actin-binding properties of Coro1A, we decided 
to investigate whether it could rescue the loss-of-function effect 
induced by the R29D missense mutation. Unlike the case of 
Coro1AE26K (Figure 5B, second row from top), we observed that 
Coro1AR29D cannot associate to the F-actin cytoskeleton when ex-
pressed in COS1 cells (Figure 5B, compare first and third rows from 
top), does not bind to actin and Arpc2 when tested in coimmunopre-
cipitation experiments (Figure 5C, compare lane 3 with lanes 1 and 
2), and, as a consequence, is found preferentially localized in deter-
gent-soluble cell fractions (Figure 5D, compare lanes 5 and 6 with 
lanes 1 and 2 and lanes 3 and 4). This is consistent with previous 
observations made with both Coro1AR29D and Coro1BR30D mutant 
proteins (Cai et al., 2007; Castro-Castro et al., 2011; Ojeda et al., 
2014). By contrast, proteins with the compound E26K and R29D mu-
tations do not show the foregoing defects and behave similarly to 
the single-Coro1AE26K mutant protein when transfected in COS1 
cells (Figure 5, B–D). However, the activity of the Coro1AE26K+R29D 
seems to be lower than that shown by Coro1AE26K, as judged by the 
detection of a small fraction of Coro1AE26K+R29D in active areas of 
membrane ruffling (Figure 5B, compare second and fourth from top).
To confirm that the effect of the E26K mutation is in-cis, we next 
compared the activity of histidine (His)-tagged Coro1A and Coro-
1AE26K proteins purified from Escherichia coli (Figure 5E) on the or-
ganization of in vitro–polymerized actin. We observed that whereas 
the addition of the wild-type protein does not induce any overt ef-
fect on F-actin (Figure 5F), Coro1AE26K under the same conditions 
promotes the aggregation of polymerized actin filaments into 
thicker and larger bundles (Figure 5F). Taken together, these results 
suggest that the E26K mutation has a direct, intrinsic effect on the 
actin- binding and -bundling activity of Coro1A.
The E26K mutation specifically eliminates the 
Coro1A-dependent activation of Rac1
We recently showed that Coro1A participates in a signaling loop 
that favors the activation of Rac1 in some cell types (Castro-Castro 
et al., 2011; Bustelo et al., 2012; Ojeda et al., 2014). To assess the 
effect of the E26K mutation in this process, we first used pull-down 
experiments with the glutathione S-transferase (GST) fused to the 
Rac1-binding domain (RBD) of Pak to measure the activation of 
endogenous Rac1 induced upon the ectopic expression of either 
Coro1AE26K-EGFP or its wild-type counterpart. Unlike the case of 
wild-type Coro1A (Figure 6A, compare first and second lanes from 
left; Castro-Castro et al., 2011), we found that Coro1AE26K does not 
induce any significant activation of Rac1 when ectopically ex-
pressed in COS1 cells (Figure 6A, compare lanes 2 and 3). Consis-
tent with this, we found that Coro1A, but not Coro1AE26K, induces 
structures composed of independent Coro1AE26K- and F-actin–posi-
tive segments (see Discussion).
Coro1AE26K-induces highly stable and functionally 
inert filaments
Further experiments indicated that the filaments formed by both ec-
topically and endogenously expressed Coro1AE26K proteins are 
more stable than the conventional F-actin structures found in control 
cells, as determined by their resistance to conventional treatments 
with cytoskeleton-disrupting agents such as latrunculin B and cyto-
chalasin D (Figure 4, A and B). Of interest, the latrunculin B treatment 
of COS1 cells (Figure 4A, compare bottom, left and middle) and 
Ptcd thymocytes (Figure 4B, compare fourth and fifth columns from 
left) favors the staining of some of the partially collapsed Coro1AE26K-
EGFP–positive filaments with phalloidin, further indicating that these 
structures contain F-actin at least in some intervening segments. 
Some staining with phalloidin is also observed when Ptcd thymo-
cytes, but not COS1 cells ectopically expressing Coro1AE26K-EGFP 
(Figure 4A, compare bottom, left and right ), are treated with cyto-
chalasin D (Figure 4B, compare fourth and sixth columns from left).
Confirming the high stability of these filaments, we found that 
they cannot be disassembled upon the ectopic coexpression of a 
constitutively active, Cherry fluorescent protein (ChFP)–tagged ver-
sion of Rac1 (G12V mutant) in COS1 cells (Figure 4C). As a conse-
quence, the Coro1AE26K-EGFP remains filament bound under those 
conditions and, unlike the case of wild-type Coro1A-EGFP (Figure 
4C, left, and Supplemental Videos S1 and S2), does not show any 
detectable translocation to the large membrane ruffles induced by 
Rac1G12V (Figure 4C, middle and right, and Supplemental Videos S3 
and S4). Coro1AE26K-EGFP decreases the size, but does not elimi-
nate, the Rac1G12V-induced membrane ruffling generated in those 
cells (Figure 4C and Supplemental Videos S3 and S4), suggesting 
that Coro1AE26K does not act as a dominant-negative mutant even 
under overexpression conditions. This stability is also found in the 
case of endogenous Coro1AE26K, since the F-actin filaments positive 
for this protein are excluded from the ruffles and cell/substratum 
contact zone of Ptcd thymocytes (Figures 1F and 4B). Finally, we 
observed that the Coro1AE26K-nucleated filaments also remain in-
tact upon the addition of a myosin II inhibitor (blebbistatin) to COS1 
cells (Supplemental Figure S3). Collectively these results indicate 
that Coro1AE26K represents a nondominant, gain-of-function mutant 
protein that leads to the formation of a highly stable and function-
ally inert meshwork of filaments in cells.
The E26K mutation has a dominant effect on Coro1A 
actin- binding properties
The Glu-26 residue is located on a surface-exposed Coro1A region 
that also contains Arg-29, a residue critical for the actin-binding 
transiently expressing EGFPs fused to either wild type (WT, top) or the Coro1AE26K (E26K, top) mutant were analyzed by 
Western blot (WB) analysis using the indicated antibodies (right) to detect the amount of endogenous (top) and ectopic 
Coro1A-EGFPs (top and middle) present in them. The amount of α-tubulin in each cell lysate was used as internal 
loading control (bottom). (E) Representative confocal images of HEK 293T cells expressing indicated EGFP-tagged 
Coro1A versions (top, green) and stained with rhodamine-labeled phalloidin (red). Potential colocalization areas 
between Coro1A proteins and F-actin had to be seen in yellow. Scale bars, 10 μm. Insets, enlarged images of the 
indicated cell areas (white open squares). (F) Confocal Z-stack three-dimensional (3D) reconstructions of Jurkat cells 
expressing the indicated ectopic Coro1A proteins (green signals) and stained with rhodamine-labeled phalloidin (red 
signals). Potential areas of colocalization between Coro1A and F-actin had to be seen in yellow (bottom). Scale bar, 
5 μm. (G) Confocal Z-stack 3D reconstructions of thymocytes isolated from mice of indicated genotypes (top) and 
stained with antibodies to Coro1A (first and third rows, red signals) and Alexa Fluor 635–labeled phalloidin (middle and 
bottom, blue signals). Potential areas of colocalization between Coro1A and F-actin had to be seen in purple (bottom). 
Scale bar, 2.5 μm.
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FIGURE 2: The Coro1AE26K mutant has increased F-actin binding capabilities. (A) Silver-stained polyacrylamide 
electrophoresis gel showing the proteins that coimmunoprecipitate with indicated ectopic proteins (top) in COS1 cells. 
Proteins of interest are indicated on the left, with the bait proteins highlighted in blue. Only mass spectrometry hits with 
scores >56 were considered (see Materials and Methods). The Coro1A band likely corresponds to proteolytic fragments 
of the baits used. Black asterisks mark nonspecific bands detected in the control EGFP immunoprecipitation. The blue 
asterisk highlights a contaminant BSA band present in the coimmunoprecipitations made with the Coro1A baits (see 
text). Molecular weight markers (MWMs) are shown on the right. IP, immunoprecipitation. (B) EGFP immunoprecipitates 
(IPs) obtained from COS1 cells expressing the indicated ectopic proteins (top) were analyzed by Western blot to detect 
the amount of coimmunoprecipitated endogenous actin (top) and Arpc2 (second from top) in each experimental 
condition. As control, filters were immunoblotted with antibodies to EGFP (third and fourth from top) to visualize the 
amount of immunoprecipitated EGFP obtained in each sample. Amount of actin (fifth from top) and Arpc2 (sixth from 
top), GAPDH (seventh from top), and ectopic EGFPs (bottom two ) present in cell supernatants before the 
immunoprecipitation step was determined by Western blot analysis of aliquots of the total cell lysates used in the 
experiments. (C) Quantitation of the coimmunoprecipitation of indicated Coro1A proteins with endogenous actin and 
Arpc2 obtained in experiments shown in B. Values normalized according to the total amount of Coro1A-EGFP 
immunoprecipitated in each case. *p ≤ 0.05 (n = 3 independent experiments). a.u., arbitrary units. (D) Coro1A 
immunoprecipitates obtained from thymocytes isolated from WT or Ptcd mice were analyzed by Western blot to detect 
the amount of coimmunoprecipitated endogenous actin (top). As control, filters were immunoblotted with antibodies to 
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larly important for the signaling of active Rac1/ArhGEF7/Pak 
complexes because, in the absence of Coro1A, these complexes 
become trapped in actomyosin-rich structures and promote the for-
mation of lamella-like cell protrusions instead of membrane ruffles 
and lamellipodia (Ojeda et al., 2014). The E26K mutation also im-
pairs the Coro1A-mediated myosin II regulatory step, because Ptcd 
thymocytes show higher amounts of myosin light chain phosphory-
lation than do controls (Figure 7A). This effect is comparable to that 
seen in Jurkat cells upon the short hairpin RNA–mediated depletion 
of the endogenous Coro1A protein (Figure 7B; Ojeda et al., 2014). 
In both cases, this effect is not linked to parallel elevations in the 
amount of phosphorylated (inactive) cofilin (Figure 7, A and B; 
Ojeda et al., 2014). Consistent with these results, we observed that 
the ectopic expression of Coro1AE26K-EGFP could not eliminate the 
actomyosin-driven elongated shape and stress fiber formation typi-
cally exhibited by CORO1A-deficient COS1 cells (Figure 7, C and 
D). Similar effects are seen when these cells are transfected with the 
inactive Coro1AR29D mutant (Figure 7, C and D; Ojeda et al., 2014). 
However, as expected (Ojeda et al., 2014), these cells do acquire 
normal shapes and cytoskeletal organization when transfected with 
wild-type Coro1A (Figure 7, C and D). Also consistent with the lack 
of proper myosin II inactivation, we found that the ectopic expres-
sion of Coro1AE26K-EGFP does not eliminate the defective cytoskel-
etal responses exhibited by CORO1A-knockdown cells upon the 
expression of active versions of Rac1 (Figure 7, E and F). As a result, 
these cells exhibit the characteristic formation of lamellar structures 
composed of radial extensions of F-actin filaments decorated by 
both phalloidin and active Rac1 (Figure 7, E and F). In agreement 
with the high stability previously observed for the Coro1AE26K-in-
duced filaments (Figure 4), we observed that both Coro1AE26K and 
the Coro1AE26K-decorated filaments are not present in any of those 
structures (Figure 7E, bottom). On the contrary, they accumulate un-
der those conditions in a thin and multifilament ring-like perinuclear 
structure (Figure 7E, bottom). These Coro1AE26K-positive filaments 
remain resistant to phalloidin staining despite being located in over-
lapping positions to the actomyosin ring (Figure 7E, bottom right). 
Taken together, these results indicate that Coro1AE26K behaves as a 
noncompetitive gain-of-function or loss-of-function mutant protein, 
depending on the expression status of Coro1A.
DISCUSSION
We showed here that Coro1AE26K, a mutant version of Coro1A 
found in immunodeficient Ptcd mice, causes quite variegated ef-
fects (gain of function, inhibition, neutral) in the normal functions of 
this protein. The gain-of-function effect leads to the formation of a 
highly stable and functionally inert meshwork of Coro1AE26K-deco-
rated filaments in cells that remain segregated away from active 
sites of actin remodeling. This effect is associated with exacerbated 
in vivo actin-binding and in vitro bundling activities of the mutant 
the translocation of both the ChFP-labeled Rac1 (Figure 6B) and 
the EGFP-labeled Pak RBD (Figure 6C) from the cytosol to the 
plasma membrane when ectopically expressed in COS1 cells 
(Castro-Castro et al., 2011). This defect is conserved in Ptcd thy-
mocytes, because we found, using GST-RBD pull-down experi-
ments, that the T-cell receptor–mediated activation of Rac1 is se-
verely compromised in these cells (Figure 6D, top). It is also 
specific, because T-cell receptor–stimulated Ptcd thymocytes show 
Erk phosphorylation kinetics similar to that exhibited by wild-type 
cells (Figure 6D, third from top). In relation with the foregoing re-
sponses, we showed previously, using luciferase-based reporter 
plasmids, that Coro1A, but not the actin binding–deficient Coro-
1AR29D mutant protein, can promote the stimulation of both c-Jun 
N-terminal kinase (JNK) and nuclear factor of activated T-cells 
(NF-AT) when ectopically expressed in those cells (Castro-Castro 
et al., 2011). JNK is a well-known downstream element of the Rac1 
route, whereas the stimulation of NF-AT requires the orchestration 
of more complex signaling outputs, including T-cell receptor–, 
phospholipase C-γ–, and calcineurin phosphatase–dependent sig-
nals (Woodrow et al., 1993a,b; Lopez-Lago et al., 2000; Kaminuma 
et al., 2001). Coro1A elicits these two responses using an actin- 
and ArhGEF7-dependent mechanism (Castro-Castro et al., 2011). 
Unlike the case of wild-type Coro1A (Castro-Castro et al., 2011), 
we observed that the ectopic expression of Coro1AE26K-EGFP 
does not lead to any detectable levels of JNK activation in either 
nonstimulated or CD3-stimulated Jurkat cells (Figure 6, E and F). 
Consistent with this, and unlike the case of the cytoskeleton-re-
lated readouts performed in COS1 cells (Figure 5), this mutation 
could not restore the activation of this downstream signaling path-
way when combined with the R29D loss-of-function mutation 
(Figure 6, E and F). By contrast, we observed that Coro1AE26K does 
promote high levels of NF-AT activity in Jurkat cells (Figure 6, G 
and H). Furthermore, the inclusion of the E26K mutation in Coro-
1AR29D overcomes the deleterious effects that the latter mutation 
induces in that biological response (Figure 6, G and H). Thus these 
results indicate that the E26K mutation induces different effects in 
actin binding (elevation), the Rac1-JNK pathway (inactivation), and 
the NF-AT route (normal signaling).
The E26K mutation impairs the Coro1A-dependent myosin 
II inactivation step
In addition to favoring Rac1 stimulation, we recently showed that 
Coro1A is important for proper myosin II inactivation. Owing to this, 
the depletion of Coro1A leads to elevated amounts of myosin light 
chain phosphorylation, increased actomyosin contractility, and the 
formation of highly elongated cells that containing large amounts of 
phospho-myosin light chain–positive stress fibers (Ojeda et al., 
2014). These defects can be eliminated using the myosin II inhibitor 
blebbistatin (Ojeda et al., 2014). This regulatory step is also particu-
Coro1A (third from top) to determine the amount of Coro1A immunoprecipitated in each sample. Amount of actin 
(fourth from top) and Coro1A (bottom) present in lysates before the immunoprecipitation step was determined by 
immunoblot analysis of aliquots of total cell lysates used in the immunoprecipitation step. hi, high exposure; lo, low 
exposure; *immunoglobulin heavy chain of the antibody used to immunoprecipiate Coro1A. γbind, immunoprecipitation 
done with beads in the absence of the antibody to Coro1A. (E) Distribution of indicated ectopic EGFPs (top) in Triton 
X-100–soluble (S) and –insoluble (I) fractions of transiently transfected COS1 cells. The distribution of Coro1A-EGFP and 
nonchimeric EGFP is shown in the first and second from the top, respectively. As control, we detected the distribution 
of endogenous proteins including actin (third from top), GAPDH (fourth from top), and histone H3 (bottom). 
(F) Distribution of endogenous Coro1A (WT) and Coro1AE26K (Ptcd) proteins present in thymocytes in the indicated 
Triton X-100–soluble (S) and –insoluble (I) fractions (top). Other markers used in this experiment are described in E. 
Similar results were obtained in two additional experiments. In B and D–F, antibodies used in the immunoblot analyses 
are indicated on the right of the appropriate Western blot strip.
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FIGURE 3: Coro1AE26K-nucleated filaments contain F-actin. (A, B) Confocal images of COS1 cells coexpressing 
RFP-LifeAct (A and B, red signals) in the presence of either Coro1A-EGFP (A, green signals) or Coro1AE26K-EGFP 
(B, green signals). In A and B, enlarged images of indicated cell areas (white open squares) are shown at the bottom. 
Potential areas of colocalization between RFP-LifeAct and Coro1A proteins had to be seen in yellow. Some of the 
filament areas found positive for RFP-LifeAct epifluorescence are indicated by arrowheads (B). Scale bars, 10 μm (top), 
5 μm (bottom); same scales in C–F. (C) Confocal images of Coro1AE26K-RFP–expressing COS1 cells stained with 
antibodies to actin. Ectopic Coro1A and endogenous actin proteins are seen in red and green, respectively. Areas of 
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in a Coro1A region potentially involved in active actin binding (see 
later discussion). Furthermore, the F-actin–rich areas present in 
those filaments do seem to contain smaller amounts of the Coro-
1AE26K mutant proteins. The observation that Coro1AE26K can stimu-
late the NF-AT route also seems to stand against the formation of 
filaments lacking actin, since we previously showed that this biologi-
cal response requires the physical interaction of Coro1A with F-actin 
(Castro-Castro et al., 2011).
The reason for the observed increased interaction of ectopic and 
endogenous Coro1AE26K proteins with actin isoforms in cells is un-
known. However, it is worth noting that the Glu-26 residue is located 
in one the blades of the Coro1A β-propeller domain that, according 
to evolutionary conservation criteria and overall basic electrostatic 
charge, may harbor one of the Coro1A actin-binding sites (Appleton 
et al., 2006). This blade also contains another key residue (Arg-29, 
Appleton et al., 2006), which, when mutated into aspartate, elimi-
nates the interaction of Coro1A with actin (Castro-Castro et al., 
2011). Electron microscopy and in silico modeling experiments sug-
gest that this region may contact two actin protomers present in 
opposite strands of the F-actin filament (Galkin et al., 2008). It can 
be speculated, therefore, that the Glu-26 residue could have a fine-
tuning role in the regulation of the affinity of the Coro1A/F-actin 
complexes in order to make possible proper cycles of complex for-
mation and disassembly during cytoskeletal processes. If this were 
the case, the E26K mutation would break such a mechanism by fa-
voring the formation of long-lasting Coro1A/actin complexes and 
highly stable F-actin filaments. This is consistent with previous ob-
servations indicating that actin-binding proteins use basic residues 
to facilitate electrostatic interactions with acidic-rich regions of actin 
(Tang and Janmey, 1996; Amann et al., 1998). Alternatively, it could 
be argued that this mutation could facilitate the interaction with ac-
tin via the elimination of inhibitory interactions with other amino 
acid sequences in Coro1A. This scenario, for example, has been 
seen in the case of the K255E mutation found in α-actinin-4, a cross-
linker actin protein involved in focal segmental glomerulosclerosis 
(Kaplan et al., 2000; Weins et al., 2007). We believe that this possi-
bility is unlikely because, if that were the case, the inclusion of the 
E26K mutation could not result in the rescue of actin binding of ac-
tin-deficient mutant versions. In any case, the elucidation of the 
atomic structure of such complexes will be required to fully under-
stand the gain-of-function effect of this mutation. Of importance, 
Glu-26 is highly evolutionarily conserved (either as such or as an 
protein (Figure 7G, thick red arrow). We detected these filaments in 
both transfected COS1 cells and thymocytes obtained from Ptcd 
mice, indicating that this phenotype cannot be solely the conse-
quence of the overexpression of the ectopically expressed mutant 
protein. Consistent with this, we showed that the wild-type and 
E26K versions of Coro1A, which are expressed at comparable 
amounts in cells, do not induce the same cellular and signaling phe-
notypes when overexpressed in cells. It is also unlikely that they 
represent nonspecific aggregation events of the mutant protein, 
because 1) other null Coro1A mutant proteins remain cytosolic and 
do not form this type of networks; 2) the formation of nonspecific 
aggregates does not seem consistent with the preservation of some 
of the biological activities of the wild-type protein by Coro1AE26K 
(NF-AT stimulation) and, of greater importance, with the functional 
rescue observed when this mutation is combined with Coro1A mu-
tants that cannot bind actin; 3) it is unclear why a nonspecific ag-
gregate would specifically trap actin and not other potential binding 
partners; and 4) there is always a correlation between the cytoskel-
etal phenotype observed and the increased association of Coro1A 
mutants with actin in vivo.
Of interest, these filaments can only be sparsely stained with 
phalloidin, LifeAct, and other actin-binding reagents. Taking into 
consideration that a single Coro1A molecule can bind to two actin 
protomers in one filament and an additional one located in the op-
posite F-actin strand (Galkin et al., 2008), we favor the possibility 
that these structures are abnormal Coro1AE26K-F-actin structures 
that cannot be stained with standard markers due to a Coro1AE26K-
mediated steric effect. A similar lack of staining with phalloidin and 
LifeAct is found, for example, in cytoskeletal structures induced by 
cofilin mutants (McGough et al., 1997) and in actin rods (Nishida 
et al., 1987; Munsie et al., 2009), a type of cofilin-rich, short F-actin 
filament structure formed in some stressed cells and pathological 
conditions (Bamburg et al., 2010). However, rods can be effectively 
stained with antibodies to actin (Nishida et al., 1987; Munsie et al., 
2009). Alternatively, it can be argued that the structures detected in 
the present study can be composed of independent segments of 
Coro1AE26K-positive and F-actin–positive filaments. Although we 
cannot formally exclude this possibility, this model seems at odds 
with the high amounts of actin found in Coro1AE26K immunoprecipi-
tates, the direct correlation of actin coimmunoprecipitation levels 
with the formation of those structures by each of the Coro1A mutant 
proteins used in our study, and the localization of the E26K mutation 
colocalization had to be seen in yellow in the right column. Enlargements of indicated cell areas (white open squares) 
are shown in the appropriate bottom images. Some of the filament areas found positive for actin immunoreactivity are 
indicated by arrows. (D) Coro1AE26K-EGFP–expressing cells were stained with Alexa Fluor 635–phalloidin and analyzed 
by confocal microscopy. Enlargements of the indicated cell areas (top, white open squares) are shown in the appropriate 
bottom images. Coro1AE26K-EGFP and F-actin signals are seen in green and blue, respectively. Areas of colocalization 
had to be seen in white. Arrowheads show segments of filaments that are phalloidin-positive (bottom). (E) COS1 cells 
coexpressing Coro1AE26K-RFP and GFP–β-actin were stained with Alexa Fluor 635–phalloidin and analyzed by confocal 
microscopy. Enlargements of the indicated cell areas (top, white open squares) are shown in the appropriate bottom 
images. Epifluorescence signals for Coro1A and β-actin are shown in red and green color, respectively. F-actin signals 
are seen in blue. Areas of colocalization for those two proteins are seen in purple. Arrowhead shows a filament segment 
that displays significant colocalization between these two proteins (bottom). (F) COS1 cells expressing the indicated 
combination of wild-type and Coro1AE26K proteins (top) were stained with Alexa Fluor 635–labeled phalloidin and 
analyzed by confocal microscopy. RFP and EGFP epifluorescence signals are seen in red and green, respectively. 
F-actin–rich areas are in blue. Areas of colocalization between RFP- and EGFP-tagged proteins are in yellow. 
Colocalization areas for RFP, EGFP, and F-actin had to be seen in white. Insets, enlarged images of the indicated cell 
areas (white open squares). (G) Confocal Z-stack 3D reconstructions of thymocytes isolated from mice of indicated 
genotypes (top) and stained with antibodies to Coro1A (top and bottom; red signals) and to actin (middle and bottom; 
green signals). Potential areas of colocalization between Coro1A and actin had to be seen in yellow (bottom). Scale bar, 
2.5 μm.
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2008). Such interpretation is consistent with previous data indicating 
that the binding of some coronins to F-actin facilitates better inter-
actions with the Arp2/3 complex in cells (Cai et al., 2005).
Unlike the foregoing defects, we found that the E26K mutation 
leads to the inactivation of the Coro1A-dependent pathways that 
contribute to the stimulation of both Rac1 and the downstream 
Rac1-JNK pathway, the regulation of cytoskeletal changes induced 
by active Rac1-ArhGEF7-Pak2 complexes, and the inactivation of 
myosin IIB (Figure 7G, steps with red crosses). However, it does not 
impair the Coro1A-mediated stimulation of the transcriptional factor 
aspartate residue), thus indicating that it will probably play similar 
roles in most coronin family members. Previous results showed that 
Coro1AE26K has a more potent Arp2/3 inhibitory activity than the 
wild-type counterpart when tested in vitro (Shiow et al., 2008). We 
surmise that this effect must be an indirect consequence of the in-
creased association of the mutant protein with actin in vivo, because 
crystal and electron microscopy structural data indicate that Glu-26 
and the rest of the first blade of the β-propeller domain are not in 
physical proximity to the C-terminal coiled-coil region that regulates 
Arp2/3 binding (Cai et al., 2005; Appleton et al., 2006; Galkin et al., 
FIGURE 4: Coro1AE26K limits F-actin filament turnover. (A) Confocal images of Coro1AE26K-EGFP–expressing COS1 cells 
treated with the indicated compounds (top) and stained with rhodamine-labeled phalloidin. Insets, enlarged image of 
the indicated cell areas (white open squares). Color code for confocal signals is indicated at the bottom. Areas of 
colocalization are seen in yellow (bottom). Scale bar, 10 μm. (B) Confocal Z-stack 3D reconstructions of thymocytes 
isolated from mice of indicated genotypes (top) and treated with indicated compounds (top) and stained with 
antibodies to Coro1A (top and bottom row) and to actin (second and third from top). Color code for confocal signals is 
indicated at the bottom. Areas of colocalization between Coro1A and actin are seen in yellow (bottom row). Scale bar, 
2.5 μm. (C) Effect of ChFP-Rac1G12V in the cytoskeleton of Coro1A-EGFP– (left) and Coro1AE26K-EGFP–expressing 
(second and third from left) COS1 cells. To visualize F-actin, transfected cells were stained with Alexa Fluor 635–
phalloidin. Insets, enlarged image of the indicated cell areas (white open squares). Color code for confocal signals is 
indicated at the bottom. Areas of triple colocalization are seen in white. Scale bar, 10 μm.
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FIGURE 5: The E26K mutation restores the association of both actin and Arpc2 to an actin binding–deficient Coro1A 
mutant. (A) Localization of the E26 and R29 residues (depicted as red and blue sticks, respectively) in the Coro1A 
β-propeller domain. Blades are numbered according to the standard nomenclature used for this type of domain. 
C, C-terminal end; N, N-terminal end. Illustration was generated using PyMol and the Coro1A crystal structure (Protein 
Data Bank: 2AQ5). (B) Representative confocal images of rhodamine-phalloidin–stained COS1 cells ectopically 
expressing indicated Coro1A-EGFPs (left). Coro1A proteins and F-actin are in green and red, respectively. Areas of 
colocalization are shown in yellow. Insets, enlarged images of the indicated cell areas (white open squares). Scale bar, 
10 μm. (C) Anti-EGFP immunoprecipitates obtained from COS1 cells expressing the indicated Coro1A-EGFPs (top) were 
analyzed by Western blot to detect the amount of coimmunoprecipitated endogenous actin (top) and Arpc2 (second 
from top) in each experimental condition. As control, filters were immunoblotted with antibodies to EGFP (third from 
top) to visualize the amount of immunoprecipitated Coro1A-EGFP obtained in each sample. Amount of actin (fourth 
from top), Arpc2 (fifth from top), and Coro1A-EGFPs (bottom) present in lysates before the immunoprecipitation step 
was determined by immunoblot using aliquots of the same cell lysates used for the immunoprecipitation experiment. 
Antibodies used in each immunoblot analyses are indicated on the right. (D) Distribution of indicated Coro1A-EGFPs 
(top) and control endogenous proteins (remaining images) in Triton X-100–soluble (S) and –insoluble (I) fractions 
obtained from transiently transfected COS1 cells. Monitored proteins and antibodies used in immunoblots are shown 
on the left and right, respectively. Similar results were obtained in two independent experiments. (E) Coomassie-stained 
gel showing aliquots of His-tagged Coro1 proteins (arrow) purified from E. coli that were used in experiments presented 
in F. (F) Representative images of in vitro polymerized and phalloidin-stained F-actin upon incubation under the 
indicated experimental conditions for 15 min. Scale bar, 30 μm.
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FIGURE 6: The E26K mutation impairs the Coro1A-mediated activation of Rac1. (A) Top, activation levels of 
endogenous Rac1 upon expression in COS1 cells of indicated EGFPs. Bottom, aliquots of total cell lysates used in the 
foregoing experiment were immunoblotted to monitor the amount of total Rac1 (second from top) and EGFPs (third 
from top) present in the lysates used in the pull-down experiments. α-Tubulin was used as loading control (bottom; 
n = 3). Note that the E26K mutant shows lower abundance here due to its preferential localization in the nonsoluble 
fraction (see Figure 2). (B) Amount of cytosolic–plasma membrane translocation of ChFP-Rac1 in the presence of the 
indicated Coro1A-EGFPs (top). On transfection of appropriate plasmids, cells were fixed, stained with Alexa Fluor 
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function effect that, due to the trapping of the mutant protein in 
nonproductive, signaling inert filaments, does not act in a dominant 
manner over the wild-type protein. These results probably explain 
the lack of overt defects that had been observed in heterozygous 
Ptcd mice (Shiow et al., 2008). Whether the Coro1AE26K mutant pro-
tein can act in a dominant manner in cells in which the actin concen-
tration could represent a more limiting factor remains to be deter-
mined. To date, this mutation has been only found in immunodeficient 
mice. Because it is not a lethal one, it would be interesting to see 
whether this or analogous mutations arise in the near future in hu-
mans and, if so, whether they exert similar or distinctive phenotypes 
to those shown by unstable or loss-of-function mutants. It would be 
also interesting to carry out a comprehensive mutational approach 
in Coro1A to identify further amino acid residues and subdomains 
involved in this cytoskeletal and signaling phenotype.
Taken together, these results provide a new mechanistic scenario 
to explain the contribution of the Coro1A E26K mutation to the pa-
thology of Ptcd mice and, in addition, reveal its implication in the 
nucleation of a quite unconventional filament network in cells. This 
mutant version might represent and interesting tool to further dis-
sect the structural and signaling roles of Coro1A in cells.
MATERIALS AND METHODS
Generation of mammalian and bacterial expression vectors
Mammalian expression vectors encoding wild-type human Coro1A-
EGFP (pCor-GFP[WT]), Coro1A-RFP (pCor-RFP[WT]), and Coro-
1AR29D-EGFP (pACC53) were previously described (Castro-Castro 
et al., 2011). Those encoding Coro1AE26K-EGFP (pVOS15) and 
Coro1AD278V-EGFP (pVOS38) were generated by site-directed muta-
genesis using the QuikChange site-directed mutagenesis kit (Agilent 
Technologies, Santa Clara, CA) to incorporate either the E26K or the 
D278V single point mutations into the human CORO1A cDNA pres-
ent in pCor-GFP[WT]. Sequences of mutagenesis primers were 5′-
CCG ACC AGT GCT ATA AAG ATG TGC GCG TC-3z (forward, 
E26K mutation underlined), 5′-GAC GCG CAC ATC TTT ATA GCA 
CTG GTC GG-3′ (reverse, E26K mutation underlined), 5′-GCC CTT 
CTT TGA CCC TGT CAC CAA CAT CGT CTA CC-3′ (forward, D278V 
mutation underlined), and 5′-GGT AGA CGA TGT TGG TGA CAG 
GGT CAA AGA AGG GC-3′ (reverse, D278V mutation underlined). 
The expression vector encoding the RFP-tagged E26K Coro1A mu-
tant (pVOS30) was obtained by site-directed mutagenesis using 
pCor-RFP[WT] as template and the oligonucleotides described. To 
generate the plasmid encoding Coro1AE26K+R29D-EGFP (pVOS32), 
NF-AT in Jurkat cells, further indicating that the effects of this 
mutation are signaling-branch specific and cannot be attributed to 
the formation of some kind of fully inert intracellular aggregates 
(Figure 7G). The preservation of the latter function is to some extent 
puzzling because we previously showed that the Coro1A-mediated 
stimulation of the Rac1-JNK and NF-AT pathways are both F-actin 
and ArhGEF7 dependent (Castro-Castro et al., 2011). This indicates 
that the NF-AT route is probably regulated by Coro1A using an Arh-
GEF7-dependent but Rac1-independent mechanism (Figure 7G). 
This interpretation is consistent with previous reports indicating that 
ArhGEF7 can stimulate NF-AT in T-cells independently of Rac1 using 
a Pak- and phospholipase C-γ–dependent pathway (Kuhne et al., 
2000; Phee et al., 2005). Alternatively, it could be speculated that an 
ArhGEF7-Cdc42-Pak–dependent pathway not affected by the E26K 
mutation could modulate this route (Manser et al., 1998; Rosen-
berger and Kutsche, 2006). This possibility seems unlikely, given that 
Coro1A does not promote the membrane translocation, activation, 
or effector functions of Cdc42 (Castro-Castro et al., 2011; Ojeda 
et al., 2014). Regardless of the cause, these data are interesting be-
cause they suggest that the previously described F-actin–depen-
dent activation of the Rac1-JNK axis by Coro1A specifically depends 
on cell rheological status, active cytoskeletal dynamics, or the sub-
cellular localization where such a stimulation step takes place. By 
contrast, the F-actin–dependent stimulation of the NF-AT pathway 
by both Coro1A and Coro1AE26K seems to exclusively require the 
assembly of any type of cytoskeleton regardless of its mechanical, 
turnover, and subcellular localization properties (Figure 7G).
Despite all of those cytoskeletal and signaling defects, we found 
that the expression of the Coro1AE26K is not deleterious, provided 
that the expression of the endogenous Coro1A protein is preserved 
in cells. Thus we observed that Coro1AE26K-expressing cells do not 
show the typical morphological changes exhibited by CORO1A-
knockdown cells under both basal and constitutive Rac1 signaling 
conditions. Furthermore, we could detect only mild defects in the 
dynamics of membrane-ruffling formation when constitutively active 
versions of Rac1 were coexpressed with Coro1AE26K in COS1 cells. 
However, Coro1AE26K does not compensate for the loss of endoge-
nous wild-type protein, and, as a consequence, it cannot rescue any 
of the cell shape and cytoskeletal defects exhibited by CORO1A-
knockdown cells under both basal and constitutively active Rac1 
expression conditions. Taken together, these results suggest that 
the pathological effects induced by Coro1AE26K in the immunodefi-
cient Ptcd mouse strain are caused by a nonconventional gain-of-
635–labeled phalloidin, and subjected to confocal microscopy to visualize ChFP-Rac1 (top and bottom, red signals), 
Coro1A-EGFP proteins (bottom, green signals), and F-actin (bottom, blue signals). Areas of colocalization between 
Rac1, Coro1A, and F-actin are shown in white (bottom). Scale bar, 10 μm. The Rac1 translocation index (TI) is indicated 
below the first row of panels (see Materials and Methods for determination of this index). **p ≤ 0.01 compared with 
control cells (n = 3). (C) Left, levels of translocation of EGFP fused to the Rac1-binding domain of Pak1 (EGFP-RBD) from 
the cytosol to the plasma membrane in the presence of indicated Coro1A-RFP proteins (left). On transfection, cells were 
fixed, stained with fluorochrome-labeled phalloidin, and subjected to confocal analysis to visualize the EGFP-RBD 
bioreporter (left, green signals), Coro1A-RFP (middle, red signals) and F-actin (right, blue signals). Areas of colocalization 
of the three proteins are shown in white (right). The white lanes present on cells (right) highlight the cell sections 
selected in each case to measure the distribution of fluorescence intensities for EGFP-RBD (green lines), Coro1A-RFP 
(red lines), and F-actin (blue lines) in the graphs on the right. (D) Top, GST-RBD pull down showing the amount of 
GTP-Rac1 present in wild-type and Ptcd thymocytes under the indicated stimulation conditions (top). Bottom, aliquots 
of the same cell lysates were analyzed by Western blot to detect the abundance and/or phosphorylation levels of 
proteins indicated on the left (bottom four). The antibodies used in the immunoblot analysis are indicated on the right. 
(E–H) Activation of JNK (E) and NF-AT (G) induced by the indicated ectopically expressed proteins in nonstimulated 
(–α-CD3) and CD3-stimulated (+α-CD3) Jurkat cells. Data represent mean and SD of a representative experiment 
performed in triplicate. The abundance of ectopic proteins (F and H, top) and α-tubulin (loading control; F and H, 
bottom) in the JNK (F) and NF-AT (H) experiments is shown. Same results were obtained in a second independent 
experiment, also performed in triplicate.
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FIGURE 7: The E26K mutation affects the Coro1A-mediated regulation of myosin II and downstream Rac1-Pak 
signaling. (A, B) Total cellular extracts from thymocytes from mice of indicated genotypes (A, top) and the indicated 
Jurkat T-cell lines (B, top) were analyzed by Western blot to detect the amount of phospho-myosin light chain (MLC; 
top), phospho-cofilin (second from top), and Coro1A (third from top). Loading controls used were GAPDH (A, bottom) 
and α-tubulin (B, bottom). Antibodies used in the immunoblot analyses are indicated on the right. Jurkat, wild-type 
Jurkat cells; J.KD1A, CORO1A-knockdown Jurkat cells; p-, phospho. (C, D) Representative images (C) and quantification 
(D; n = 3; 150 cells/transfection) of the effect of indicated Coro1A-EGFPs in the cytoskeletal and morphological 
phenotype of CORO1A-knockdown COS1 cells (referred to as KD1A.1 cells). In C, color code for confocal signals is 
indicated below the images. Colocalization of Coro1A-EGFP and F-actin is shown in yellow. Scale bar, 10 μm. 
(E, F) Representative images (E) and quantification (F; n = 3; 150 cells/condition) of the effect of indicated Coro1A-
EGFPs in the cytoskeletal defects shown by ChFP-Rac1G12V–expressing CORO1A-knockdown COS1 cells. In E, the code 
for confocal signals is indicated below the images. Areas of colocalization of active Rac1, Coro1A-EGFPs proteins, and 
F-actin are shown in white. Scale bar, 10 μm. (G) Summary of results obtained in this work. The depicted pathway is 
based on observations made in this work and previous publications (Castro-Castro et al., 2011; Ojeda et al., 2014). In all 
cases, activation and inactivation steps are indicated by arrows and blunted lanes, respectively. Broken lanes indicate 
signaling cascades. Enhanced and reduced activities exhibited by the Coro1AE26K mutant protein are indicated by thick 
arrows and crosses (both in red), respectively. Effects induced by the actin-binding deficient Coro1AR29D mutation are 
shown in blue. RhoGDI, Rho GDP dissociation inhibitor. See Discussion for further details.
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tained as described in RPMI-1640 supplemented with 10% FBS and 
100 U/ml penicillin and streptomycin. When necessary, Jurkat cells 
were stimulated for the indicated periods of time with antibodies to 
human CD3 (10 μg/ml; Castro-Castro et al., 2011; Barreira et al., 
2014). The stable CORO1A-knockdown COS1 (KD1A.1 cell clone) 
and Jurkat (J.KD1A cell pool) cells were generated, characterized, 
and cultured as described elsewhere (Castro-Castro et al., 2011; 
Ojeda et al., 2014).
Transient transfections
COS1 and HEK 293T cells were grown onto six-well plates and 
transfected using Lipofectamine 2000 (Invitrogen). To that end, 1 μg 
of the appropriate plasmid DNA and 3 μl of Lipofectamine 2000 
were diluted separately in 100 μl of serum-free DMEM, and the two 
solutions were mixed, incubated for 20 min at room temperature, 
and then added onto cells. Transfected cells were trypsinized 24 h 
later, seeded onto 0.001% polylysine (Sigma-Aldrich)-coated cover-
slips, and fixed 24 h later. To transfect Jurkat cells, 20 μg of plasmid 
DNA was added to 2 × 106 cells diluted in 2 ml of R buffer (Invitro-
gen) and the mix subjected to two electroporation cycles at 1.7 mV 
(20 ms each) using the Neon transfection system (Invitrogen). Elec-
troporated cells were transferred to standard culture media for 36 h 
and subsequently plated onto 0.001% polylysine-coated coverslips, 
allowed to settle for 20 min, fixed, and stained.
Isolation and culturing of thymocytes from Ptcd mice
All animal work was done following the protocols approved by the 
bioethics committees of both the University of Salamanca and the 
Consejo Superior de Investigaciones Científicas. Cataract-Shionogi 
(CTS/Shi) mice carrying the Ptcd locus (Ikegami et al., 1988; Shiow 
et al., 2008) in the B6 genetic background were provided by J. 
Serody (University of North Carolina at Chapel Hill, Chapel Hill, NC). 
Genotyping of these mice was done using a quantitative reverse 
transcription-PCR approach with three simultaneous primers to dis-
tinguish the natural wild-type and Ptcd alleles of the Coro1A gene 
according their specific cycle threshold (Ct) amplification values. Oli-
gonucleotides used were 5′-CAA GGC TGA CCA GTG CTA AG-3′ 
(forward for wild-type sequence), 5′-CAA GGC TGA CCA GTG CTA 
AA-3′ (forward for Ptcd allele sequence), and 5′-GTT GAC AGC 
GCA GAA GCC A-3′ (reverse, common for both alleles). The two 
forward oligonucleotides will yield different Ct depending on their 
specific match with either wild-type or mutant DNA sequences.
To isolate thymocytes from those mice, single-cell suspensions 
were obtained by mechanical homogenization of thymi in 3 ml of 
phosphate-buffered saline (PBS) solution supplemented with 2% 
BSA and 0.5 mM EDTA, washed once by low-speed centrifugation 
and resuspension in the buffer, subjected to 0.17 M NH4Cl lysis to 
eliminate erythrocytes, and washed twice as described. For immu-
nofluorescence experiments, final cell pellets were resuspended in 
PBS solution, seeded onto mouse anti–CD3-coated coverslips 
(2 μg/ml; BD Biosciences), allowed to settle for 10 min, fixed, and 
stained as described. When indicated, cells were treated with latrun-
culin B and cytochalasin D as described. For immunoblot and bio-
chemical determinations, thymocytes were kept in suspension and, 
when indicated, stimulated with hamster antibodies to mouse CD3 
(10 μg/ml) for the indicated periods of time.
Immunofluorescence experiments
Samples were fixed, permeabilized, stained, and mounted as previ-
ously described for most of the confocal microscopy experiments 
presented in this work (Castro-Castro et al., 2011). However, in the 
case of γ-actin localization experiments, we followed a specific 
we mutagenized the pVOS15 using oligonucleotides 5′-CCA GTG 
CTA TAA AGA TGT GGA CGT CTC ACA GAC CAC C-3′ (forward, 
mutations underlined) and 5′-GGT GGT CTG TGA GAC GTC CAC 
ATC TTT ATA GCA CTG G-3′ (reverse, mutations underlined). The 
pRFP-Ruby-N1-LifeAct (Ojeda et al., 2014) plus vectors encoding 
ChFP-tagged Rac1 (pmCherry-Rac1; Castro-Castro et al., 2011) and 
ChFP-tagged Rac1G12V (pmCherry-Rac1G12V; Ojeda et al., 2014) 
were provided by M. A. del Pozo (Centro Nacional de Investigacio-
nes Cardiovasculares, Madrid, Spain). The expression vectors en-
coding EGFP-Rac1Q61L (pNM42), EGFP-Vav1Onc (N-terminal deletion 
lacking the N-terminal CH and Ac regions, pNM108), and the Pak1 
RBD domain fused to EGFP (pJRC45) were previously described 
(Lopez-Lago et al., 2000; Ruiz et al., 2007; Castro-Castro et al., 
2011). The GFP-β-actin (pGreen-FP-vector-actin; 558721)– and 
mCherry-γ-actin (mCherry-Gamma-Actin2-C-18; 55049)–encoding 
expression vectors were from BD PharMingen (San Jose, CA) and 
Addgene (Cambridge, MA), respectively. The pFA2-cJun (JNK acti-
vation assays) luciferase reporter plasmid was from Agilent Tech-
nologies. The pNF-AT-Luc (used in NF-AT activation assays) was pro-
vided by G. Crabtree (Stanford University Medical School, Stanford, 
CA). The control pRL-SV40 plasmid encoding the Renilla luciferase 
under the control of a constitutive promoter was from Promega 
(Durham, NC).
To generate the bacterial expression vectors encoding His-
tagged Coro1A (pVOS33) and Coro1AE26K (pVOS34), XhoI/BamHI-
digested fragments obtained from pCor-GFP[WT] and pVOS15 
were ligated independently into different aliquots of the XhoI-BglII-
linearized pTrcHisA plasmid (Invitrogen, Carlsbad, CA). All plasmids 
were sequence verified in the Genomics and Proteomics Unit of our 
Center. The vector (pGST-Pak-BD) encoding the GST-Rac1–binding 
domain of Pak1 was provided by R. A. Cerione (Department of 
Molecular Medicine, College of Veterinary Medicine, Cornell Uni-
versity, Ithaca, NY).
Immunological reagents
Rhodamine- and Alexa Fluor 635–labeled phalloidin were obtained 
from Molecular Probes/Invitrogen. Rabbit polyclonal antibodies to 
Coro1A, myosin IIB, and Arpc2 were purchased from Encor Biotech-
nology (Gainesville, FL), Covance (Princeton, NJ), and Merck Milli-
pore (Darmstadt, Germany), respectively. Mouse monoclonal anti-
bodies to vimentin and rabbit polyclonal antibodies to histone H3 
were from Abcam (Cambridge, UK). Mouse monoclonal antibodies 
to pancytokeratin, rabbit polyclonal antibodies to (GADPH, and 
goat antibodies to all actin isoforms were obtained from Santa Cruz 
Biotechnology (Dallas, TX). Mouse monoclonal antibodies to γ-
actin, α-tubulin, and GFP were from Serotech (Burlington, ON, Can-
ada), Calbiochem/Merck Millipore, and Covance, respectively. The 
mouse and hamster antibodies to human and mouse CD3 were 
from Merck Millipore and BD PharMingen, respectively. Rabbit poly-
clonal antibodies to phospho-myosin light chain, phospho-cofilin, 
and phospho-Erk were from Cell Signaling (Boston, MA). When re-
quired, appropriate Cy2- and Cy3-labeled secondary antibodies 
were used (Jackson ImmunoResearch, West Grove, PA).
Cell lines and tissue culture
COS1 and HEK 293T cells were maintained at 37°C and a 5% CO2 
atmosphere in DMEM supplemented with 10% fetal bovine serum 
(FBS) plus 1% l-glutamine plus 100 U/ml of both penicillin and strep-
tomycin (Sigma-Aldrich, St. Louis, MO). When indicated, COS1 cells 
were incubated with 2 μM cytochalasin D (15 min; Sigma-Aldrich), 
10 μM latrunculin B (20 min; Enzo Life Sciences, Farmingdale, NY), 
or 50 μM blebbistatin (2 h; Sigma-Aldrich). Jurkat cells were main-
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peptide calibration mixture containing seven peptides (Peptide 
Calibration Standard #206196; Bruker Daltonics) covering the m/z 
range 1000–3200. Every spectrum was internally calibrated using 
selected signals arising from trypsin autoproteolysis (842.510- and 
2211.105-Da peptides) to reach a typical mass measurement accu-
racy of ±30 ppm. Each raw spectrum was opened in FlexAnalysis 
3.0 (Bruker Daltonics) software and processed and analyzed using 
the following parameters: signal-to-noise threshold of 1, Savitzky–
Golay algorithm for smoothing, tangential algorithm for baseline 
subtraction, and centroid algorithm for monoisotopic peak assign-
ment. In all cases, resolution was >9000. All known contaminants 
(trypsin autoproteolysis and known keratin peaks) were excluded 
during the process.
Peaks were sent to the Mascot Server (version 2.1) using Bio 
Tools 3.0 (Bruker Daltonics) software and searched against SwissProt 
database (SwissProt 2011_09; 532,146 sequences; 188,719,038 
residues) for protein identification. Searches were carried out using 
the following parameters: Homo sapiens species (20,249 se-
quences), up to one missed tryptic cleavage, mass accuracy of 
100 ppm, MH+ monoisotopic masses, carbamidomethyl cysteine as 
fixed modification, and methionine oxidation as variable modifica-
tion. Mowse scores with a value >56 for SwissProt database were 
considered as significant (p < 0.05). All proteomics studies were car-
ried out by technical personnel of the Genomics and Proteomics 
Unit of our Center.
Immunoprecipitation, pull-down, and blotting experiments
Cell lysis, electrophoresis, and Western blot techniques were done 
exactly as previously described (Castro-Castro et al., 2011). Immu-
noprecipitations of EGFP-tagged proteins were carried out using 
the GFP-trap reagent (ChromoTek, Planneg-Martinsried, Germany). 
To analyze Triton X-100–soluble and –insoluble fractions, cells were 
lysed as described, and pellets obtained were solubilized in 80 mM 
Tris-HCl (pH 6.8) containing 2% SDS, 10% glycerol, 0.02% bromo-
phenol, and 5% mercaptoethanol. The determination of Rac1-GTP 
levels in transfected COS1 cells and CD3-stimulated thymocytes 
from control and Ptcd mice was done using pull-down experiments 
with the GST-Rac1 binding domain of Pak1 fusion protein as previ-
ously indicated (Castro-Castro et al., 2011). In all cases, proteins and 
total cellular extracts were analyzed by SDS–PAGE and immunoblot 
following standard procedures. In all cases, protein signals in West-
ern blot analyses were revealed using chemiluminescence with 
horseradish peroxidase coupled to secondary antibodies (GE 
Healthcare Life Biosciences, Buckinghamshire, UK).
Video recordings
Subconfluent cells plated onto 35-mm culture plates were trans-
fected with ChFP-Rac1G12V and either pCor-GFP (WT) or pVOS15 
(encoding Coro1AE26K-EGFP) plasmids and, 24 h later, analyzed us-
ing a 20× objective (Olympus) in a DeltaVision microscope (Image 
Solutions). Images were taken using the Resolve3D softWoRx-
Aquire software (version 5.5.0). Capture settings were 0.8-s expo-
sure time with 1-s intervals. Videos are played at 10 frames/s.
Protein purification from E. coli
Exponentially growing cultures E. coli DH5α cells containing ei-
ther the pVOS33 or pVOS34 plasmid were treated with 1 mM 
isopropyl-β-d-1-thiglucopyranoside (Roche Applied Science, 
Basel, Switzerland) for 2 h at 30°C. Cells were then harvested by 
centrifugation at 5500 rpm for 15 min at 4°C and lysed by sonica-
tion in lysis buffer (50 mM phosphate buffer, pH 8.0, 300 mM 
NaCl, and 10 mM imidazole). After centrifugation at 10,000 rpm 
protocol (Dugina et al., 2009). Briefly, cells were fixed in 1% parafor-
maldehyde in prewarmed DMEM for 30 min, treated with MetOH at 
−20ºC for 5 min, permeabilized in TBS-T (25 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 0.1% Tween-20) for 10 min, washed three times with 
TBS-T, blocked in a 2% BSA in TBS-T for 30 min, and then stained 
with antibodies to γ-actin for 3 h and the secondary antibody (di-
luted in blocking solution) for 1 h. In all cases, stained preparations 
were mounted onto microscope slides using Mowiol (Calbiochem) 
and analyzed using a Leica SP5 confocal microscope and a 63× 
objective (Leica). Microscope images were exported and processed 
for presentation using Canvas 9.0.4 software (ACD Systems, Seattle, 
WA). When required, profiles of fluorescence intensity along cells 
were made using ImageJ software (National Institutes of Health, 
Bethesda, MD). The Rac1 translocation index obtained in each exper-
imental condition was calculated as previously described (Castro-
Castro et al., 2011). To this end, ChFP-positive cells were selected 
from confocal images obtained under the indicated experimental 
conditions and scored 0 for no detectable Rac1 in the plasma mem-
brane, 1 for weak Rac1 plasma membrane staining, and 2 for high 
Rac1 localization in the plasma membrane. The Rac1 translocation 
index to the plasma membrane was calculated as (y + 2z)/(x + y + z), 
where x, y, and z are the numbers of cells scored as 0, 1, or 2, respec-
tively. When histograms are included, they refer to the percentage of 
a given phenotype in the total population of fluorescent protein–ex-
pressing cells. In these cases, we define as “spread,” “contracted,” 
and “contracted + stress fibers” cells displaying typical morphology 
of COS1 cells, cells with smaller areas than control ones, and cells 
with reduced cell size plus the presence of prominent stress fibers, 
respectively. When using the term “ruffles,” we refer to cells display-
ing the large membrane ruffles typically elicited by active versions 
of Rac1. Only cells displaying ruffles in more than half of the cell 
perimeter were included in this category. The term “lamella-like” is 
used to describe cells displaying unpolarized cytoplasmic extensions 
that were supported by radial, phalloidin- and Rac1-decorated 
F-actin filaments. Quantification was done using 150 cells in three 
independent experiments.
Proteomics analyses
On GFP-trap immunoprecipitation and electrophoretic fraction-
ation of protein complexes, desired silver-stained gel slices were 
manually excised, destained with a 1:1 solution of 15 mM 
K3[Fe(CN)6] (Merck) and 50 mM Na2S2O3 (Merck) for 15 min, rinsed 
with water, and dehydrated with 100% CH3CN (Fisher). Plugs were 
then treated stepwise with 10 mM dithiothreitol (Sigma-Aldrich) in 
25 mM (NH4)HCO3 (Sigma-Aldrich) at 56ºC for 45 min and 55 mM 
iodoacetamide (Sigma-Aldrich) in 50 mM (NH4)HCO3 at room tem-
perature for 30 min and rinsed with 100% CH3CN and 20 mM (NH4)
HCO3. Modified porcine trypsin (Promega) at a final concentration 
of 3 ng/μl in 20 mM (NH4)HCO3 was added to gel pieces and incu-
bated at 37°C for 16 h. Plugs were then acidified by adding 1 μl of 
5% HCOOH (Merck), incubated for 15 min at 37ºC, and finally dried 
in a speed vacuum system. For matrix-assisted laser desorption/
ionization time-of-flight (MALDI-TOF) peptide mass fingerprinting, 
a 0.5-μl aliquot of matrix solution (5 g/l 2,5-dihydroxybenzoic acid 
in a 33% aqueous solution of CH3CN containing 0.1% CF3CO2H 
[Merck]) plus 1 μl of the aforementioned peptide extraction solution 
was manually loaded onto a 400-μm-diameter AnchorChip target 
plate probe (Bruker Daltonics, Billerica, MA) and allowed to dry at 
room temperature. Samples were analyzed on an Ultraflex MALDI-
TOF mass spectrometer (Bruker Daltonics) using an acquisition 
mass range of 600–4000 Da. To this end, the equipment was first 
externally calibrated using protonated mass signals from a standard 
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for 10 min at 4°C, supernatants were collected and incubated 
in batch with nickel-nitriloacetic acid agarose beads (Qiagen, 
Limburg, The Netherlands) at 4°C under continuous rotation. After 
2 h, beads were collected by centrifugation and washed three 
times in lysis buffer with 20 mM imidazole, and proteins were 
eluted in lysis buffer containing 250 mM imidazole. The GST-Rac1 
binding domain of Pak1 protein was induced as described and pu-
rified using glutathione-coated beads (GE Healthcare). Beads with 
the purified protein were stored frozen until experimental use. In all 
cases, protein concentration was determined by running aliquots 
of both the purified His-tagged protein and GST fusion protein–
coated beads in SDS–PAGE in the presence of known concentra-
tions of BSA as standard and stored at –20°C until further use.
Studies with in vitro–polymerized actin
F-actin was obtained by adding 5 μl of a 10-fold-concentrated actin 
polymerization buffer (100 mM Tris-HCl, pH 7.5, containing 1 M KCl, 
20 mM MgCl2, and 10 mM ATP) to 45 μl of a purified rabbit muscle 
actin solution (2 μg/μl; A2522; Sigma-Aldrich) followed by a 1-h-
long incubation at room temperature. The solution obtained was 
incubated with rhodamine-labeled phalloidin (70 nM) for 20 min at 
room temperature and subsequently supplemented with 1 μM indi-
cated His-tagged Coro1A proteins purified from E. coli. After 15 min 
at room temperature, aliquots of the incubation mix were placed 
between a microscope slide and a coverslip, sealed, and analyzed 
by immunofluorescence microscopy using a 63× objective (Leica) in 
a Leica DM 6000B microscope.
JNK and NF-AT luciferase reporter assays
These techniques have been described elsewhere (Barreira et al., 
2014).
Image processing
Images were assembled and processed for final figure presentation 
using Canvas 9.0.4 (ACD Systems).
Statistical analyses
Data from at least three independent experiments were analyzed 
using the Student’s t test. p ≤ 0.05 was considered as statistically 
significant.
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